Lista de obras - Douglas Sato - Dominio Público Uruguay

Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star

artículo científico publicado en 2015

Anti-N-methyl-D-aspartate receptor encephalitis with multiphasic demyelination

artículo científico publicado en 2014

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders

scientific article published on 01 January 2014

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

artículo científico publicado en 2013

Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: diagnostic considerations

artículo científico publicado en 2013

Atypical presentations of neuromyelitis optica

artículo científico publicado en 2011

Author response

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies.

artículo científico publicado en 2017

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications

artículo científico publicado en 2018

Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks

artículo científico publicado en 2014

Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis

artículo científico publicado en 2014

Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.

artículo científico publicado en 2015

Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.

artículo científico publicado en 2013

Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein

scientific article published on 23 October 2018

Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America

artículo científico publicado en 2018

Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.

artículo científico publicado en 2018

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

artículo científico publicado en 2012

Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice

artículo científico publicado en 2020

Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays

scientific article published on 15 November 2019

Different etiologies and prognoses of optic neuritis in demyelinating diseases

artículo científico publicado en 2016

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

artículo científico publicado en 2014

Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology

artículo científico publicado en 2015

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.

artículo científico publicado en 2015

Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis

artículo científico publicado en 2014

Isolated rhombencephalitis with good clinical recovery.

artículo científico publicado en 2017

Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.

artículo científico publicado en 2016

Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report

artículo científico publicado en 2015

MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.

artículo científico publicado en 2017

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

artículo científico publicado en 2015

MOG-IgG associated optic neuritis is not multiple sclerosis.

artículo científico publicado en 2017

MOG-IgG serological status matters in paediatric ADEM

artículo científico publicado en 2014

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

artículo científico publicado en 2018

MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity - Yes

scientific article published on 17 December 2019

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1

artículo científico publicado en 2015

Neuromyelitis Optica Spectrum Disorders.

artículo científico publicado en 2017

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

artículo científico publicado en 2015

Neuromyelitis optica without typical opticospinal phenotype

artículo científico publicado en 2010

Neutralizing Antibodies Are Associated with a Reduction of Interferon-^|^beta; Efficacy during the Treatment of Japanese Multiple Sclerosis Patients

scientific article published on 01 October 2012

Oral fingolimod to treat multiple sclerosis: see your cardiologist first

scientific article published on 01 September 2014

Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis

scientific article published on 12 November 2018

Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.

artículo científico publicado en 2016

Quality of life goes beyond the medical priorities in multiple sclerosis: assessing the impact of social support network

artículo científico publicado en 2017

Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders

artículo científico publicado en 2019

Serological markers associated with neuromyelitis optica spectrum disorders in South India

artículo científico publicado en 2016

Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis

artículo científico publicado en 2014

Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

artículo científico publicado en 2014

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.

artículo científico publicado en 2015

Sometimes less is more in multiple sclerosis drug switching.

artículo científico publicado en 2016

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications

artículo científico publicado en 2016

The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients

artículo científico publicado en 2015

Time to target brain atrophy and neurodegeneration in multiple sclerosis

artículo científico publicado en 2016

Unraveling B-lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets

scientific article published on 09 September 2020

Update on biomarkers in neuromyelitis optica

artículo científico publicado en 2015

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

artículo científico publicado en 2015

Viral encephalitis: a practical review on diagnostic approach and treatment

scientific article published on 09 September 2019

Lista de obras de Douglas Sato

Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star

Anti-N-methyl-D-aspartate receptor encephalitis with multiphasic demyelination

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: diagnostic considerations

Atypical presentations of neuromyelitis optica

Author response

Author response

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications

Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks

Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis

Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.

Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.

Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein

Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America

Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice

Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays

Different etiologies and prognoses of optic neuritis in demyelinating diseases

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.

Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis

Isolated rhombencephalitis with good clinical recovery.

Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.

Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report

MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

MOG-IgG associated optic neuritis is not multiple sclerosis.

MOG-IgG serological status matters in paediatric ADEM

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity - Yes

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1

Neuromyelitis Optica Spectrum Disorders.

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Neuromyelitis optica without typical opticospinal phenotype

Neutralizing Antibodies Are Associated with a Reduction of Interferon-^|^beta; Efficacy during the Treatment of Japanese Multiple Sclerosis Patients

Oral fingolimod to treat multiple sclerosis: see your cardiologist first

Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis

Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.

Quality of life goes beyond the medical priorities in multiple sclerosis: assessing the impact of social support network

Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders

Serological markers associated with neuromyelitis optica spectrum disorders in South India

Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis

Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.

Sometimes less is more in multiple sclerosis drug switching.

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications

The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients

Time to target brain atrophy and neurodegeneration in multiple sclerosis

Unraveling B-lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets

Update on biomarkers in neuromyelitis optica

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

Viral encephalitis: a practical review on diagnostic approach and treatment